Yale Global Tic Severity Scale (YGTSS)

Abstract

The Yale Global Tic Severity Scale (YGTSS) is an internationally recognized, clinician-administered, semi-structured assessment battery designed to quantify the multifaceted phenomenology, severity, and functional impact of motor and phonic (vocal) tics in individuals diagnosed with Tourette Syndrome (TS) and Persistent (Chronic) Motor or Vocal Tic Disorders. Developed by James F. Leckman and colleagues in 1989 at the Yale Child Study Center, the YGTSS has established itself as the gold-standard outcome measure in pediatric and psychiatric neurodevelopmental research and clinical trials. The instrument comprehensively evaluates symptoms across five discrete symptom dimensions for both motor and phonic tics: Number, Frequency, Intensity, Complexity, and Interference. Each dimension is rated on an anchored ordinal scale from 0 to 5, generating a Total Motor Tic Score (range: 0–25) and a Total Phonic Tic Score (range: 0–25), which sum to yield the Total Tic Score (range: 0–50). Additionally, an independent 50-point Overall Impairment Scale measures functional disruptions across academic, occupational, familial, and social domains, culminating in a Global Severity Score (range: 0–100). Psychometric investigations consistently document excellent internal consistency (Cronbach’s alpha ≥ .91), robust inter-rater reliability (intraclass correlation coefficients typically exceeding .85), stable test-retest reliability, and well-demonstrated convergent and discriminant validity against measures of obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, anxiety, and depressive symptom severity. Factor-analytic studies support a two-factor structure corresponding to motor and phonic tic dimensions, maintaining robust structural validity across diverse developmental cohorts.

Keywords

Yale Global Tic Severity Scale, YGTSS, Tourette Syndrome, Tic Disorders, Motor Tics, Phonic Tics, Psychometrics, Clinical Assessment, Neurodevelopmental Disorders, Impairment Rating

Authors

The Yale Global Tic Severity Scale was initially conceptualized, operationalized, and psychometrically validated by a multi-disciplinary team of child psychiatrists, psychologists, and clinical nurse specialists at the Yale Child Study Center, Yale University School of Medicine (New Haven, Connecticut, USA). The primary original investigators include:

• James F. Leckman, M.D., Ph.D. — Neison Harris Professor of Child Psychiatry, Pediatrics, and Psychology at the Yale Child Study Center, Yale University School of Medicine.
• Mark A. Riddle, M.D. — Professor of Psychiatry and Behavioral Sciences and Pediatrics, Division of Child and Adolescent Psychiatry, Johns Hopkins University School of Medicine (formerly of the Yale Child Study Center).
• Martha T. Hardin, Ph.D. — Research Psychologist, Yale Child Study Center, Yale University School of Medicine.
• Sharon I. Ort, R.N., M.S.N. — Clinical Research Nurse Specialist, Yale Child Study Center, Yale University School of Medicine.
• Kathy L. Swartz, M.S.W. — Clinical Social Worker and Research Associate, Yale Child Study Center, Yale University School of Medicine.
• Jim Stevenson, Ph.D. — Department of Psychology, University of Southampton (collaborating psychometrician).
• Donald J. Cohen, M.D. (Senior Investigator) — Former Irving B. Harris Professor of Child Psychiatry, Pediatrics, and Psychology, and Director of the Yale Child Study Center.

Subsequent psychometric refinements, structural factor-analytic validations, and treatment-response thresholds have been led by researchers including Eric A. Storch, Ph.D. (Baylor College of Medicine), Tanya K. Murphy, M.D. (University of South Florida), and Lawrence Scahill, M.S.N., Ph.D. (Emory University School of Medicine).

Purpose

The primary clinical and psychometric purpose of the YGTSS is to provide a comprehensive, objective, and standardized clinician-rated quantification of tic severity and tic-related functional impairment over a defined surveillance window, conventionally operationalized as the preceding week (past 7 to 10 days). Rather than serving as a categorical diagnostic classification system or an automated screening inventory, the YGTSS operates as an evaluative dimensional measurement tool designed to characterize symptom expression and quantify clinical change over time.

Clinically, tic disorders such as Tourette Syndrome and persistent motor or vocal tic disorders are inherently dynamic, characterized by waxing and waning trajectories, variable anatomical distributions, and context-dependent fluctuations in intensity and frequency. Consequently, categorical checklists or brief cross-sectional observation windows often fail to capture the ecological reality of the patient’s symptom burden. The YGTSS overcomes this challenge by pairing an exhaustive symptom inventory with a semi-structured clinical interview that engages both the child/adolescent and their caregivers. This dual-informant framework enables the clinician to synthesize real-time observation, subjective internal experiences (such as premonitory urges and suppressibility), and collateral caregiver observations across academic, domestic, and recreational settings.

In clinical trials and empirical neurobehavioral research, the YGTSS serves as the universal benchmark for defining therapeutic efficacy, treatment response, and remission criteria. The instrument is sensitive to pharmacotherapeutic interventions (e.g., alpha-2 adrenergic agonists, typical and atypical antipsychotics, vesicular monoamine transporter 2 inhibitors) and evidence-based psychotherapeutic protocols, most notably Comprehensive Behavioral Intervention for Tics (CBIT) and Exposure and Response Prevention (ERP). Advanced signal detection analyses and clinical trial consensus panels have systematically utilized the YGTSS Total Tic Score to establish evidence-based cutoffs: a 25% to 35% reduction in the Total Tic Score is widely accepted across modern clinical trials as indicative of a clinically meaningful treatment response, correlating strongly with ratings of ‘much improved’ or ‘very much improved’ on the Clinical Global Impressions-Improvement (CGI-I) scale.

Psychological Construct

The YGTSS evaluates the multi-layered construct of tic severity, conceptualized as a composite neurodevelopmental and behavioral phenomenon comprised of multiple observable and inferable clinical parameters. Rather than treating tic severity as a monolithic entity simply defined by the frequency of movements or vocalizations, the scale deconvolutes the construct into five discrete anatomical and behavioral dimensions evaluated separately across two symptom modalities (Motor and Phonic), supplemented by a distinct appraisal of global functional impairment.

1. The Motor Tic Modality

Motor tics are sudden, rapid, recurrent, non-rhythmic motor movements involving discrete muscle groups. The YGTSS systematically evaluates motor tics across five distinct dimensions:

• Number: Quantifies the repertoire or diversity of discrete motor tics present during the observation period, ranging from an isolated, single motor manifestation (e.g., eye blinking alone) to multiple distinct tics exhibiting simultaneous or complex sequential patterns.
• Frequency: Evaluates the temporal density and recurrence rate of motor episodes throughout the waking day, distinguishing between isolated, brief bouts with long tic-free intervals versus nearly continuous, unrelenting tic cascades.
• Intensity: Captures the biomechanical force, vigor, and neuromuscular energy expended during tic execution, differentiating subtle, barely perceptible twitches from exaggerated, violent, or potentially tissue-injurious contractions (e.g., severe cervical whiplash tics).
• Complexity: Differentiates elementary, rapid, uncoordinated muscle jerks (simple tics such as shoulder shrugging or nose wrinkling) from purposeful-appearing, coordinated, prolonged motor sequences (complex tics such as touching rituals, echopraxia, copropraxia, or coordinated body posturing).
• Interference: Measures the extent to which motor tics disrupt, delay, or truncate intentional actions, purposeful motor behavior, or interpersonal communication (e.g., a hand tic causing a child to drop writing implements or a facial tic interrupting visual tracking).

2. The Phonic (Vocal) Tic Modality

Phonic tics encompass any noise, sound, or linguistic utterance produced by the contraction of diaphragmatic, laryngeal, pharyngeal, or nasal musculature. Like motor tics, phonic tics are dissected into five parallel dimensions:

• Number: Assesses the clinical variety of vocal tics, spanning from a solitary phonic sound (e.g., repetitive throat-clearing) to a diverse repertoire of varied sounds, phonemes, and verbalizations.
• Frequency: Quantifies the distribution of vocal outbursts across the day, tracking intervals between vocal emissions.
• Intensity: Measures auditory volume, acoustic amplitude, and explosive force, spanning from quiet, barely audible snorts or mumbles to loud, disruptive shouts, barking sounds, or explosive verbalizations.
• Complexity: Discriminates brief, meaningless acoustic sounds (simple phonic tics such as grunting, sniffing, or coughing) from linguistically meaningful words, phrases, sentences, sudden changes in pitch/cadence, palilalia, echolalia, or coprolalia.
• Interference: Evaluates the disruptive impact of vocal emissions on the flow of verbal discourse, speech fluency, classroom participation, or conversational reciprocity.

3. Functional Impairment

A central theoretical premise of the YGTSS is that the topographic severity of tics does not linearly predict personal distress or functional decrement. The construct of Overall Impairment reflects the secondary psychosocial fallout of the disorder. It captures subjective distress, social stigmatization, peer victimization, familial tension, academic disruptions, and occupational limitations caused directly by the motor and vocal tics. By isolating impairment as an independent 50-point rating, the scale prevents clinical severity scores from being falsely inflated or deflated by an individual’s psychological resilience or environmental accommodations.

Theoretical Framework

The YGTSS is rooted in modern neuropsychiatric and developmental neurobiology models of Tourette Syndrome. Early historical psychodynamic frameworks erroneously conceptualized tics as physical conversions of repressed hostility, sexual impulses, or emotional conflicts. In sharp contrast, the developmental model underlying the Yale Child Study Center’s operationalization conceives of tics as sensorimotor gating failures originating from disruptions within cortico-striato-thalamo-cortical (CSTC) sensorimotor circuitry.

1. Cortico-Striato-Thalamo-Cortical (CSTC) Dysregulation

Contemporary neurobiological theory posits that tics arise from disinhibition in the motor loop of the CSTC circuits. Within this model, focal aberrant activity in the striatum leads to excessive, disinhibited projection from the thalamus back to the primary motor cortex and supplementary motor area (SMA). The YGTSS captures this neurobiological phenomenon directly through its dimensions of Intensity, Frequency, and Complexity. Simple tics correspond to circumscribed disinhibition of primary motor pathways, whereas complex tics reflect recruitment of associative and limbic circuits, culminating in coordinated, semi-purposeful motor programs.

2. The Premonitory Urge and Behavioral Reinforcement Loops

Modern cognitive-behavioral and neurodevelopmental frameworks emphasize the phenomenon of the premonitory urge — a focal or generalized somatic, sensory tension preceding the execution of a tic. From a behavioral learning perspective, the execution of the tic provides immediate, temporary relief from this aversive internal sensation, thereby reinforcing the behavior through negative reinforcement. The dimensional structure of the YGTSS aligns with this framework by allowing clinicians to contextualize how frequency and complexity interact with behavioral reinforcement mechanisms, providing a quantitative baseline for interventions like CBIT that disrupt the urge-to-tic contingency.

Validity

The construct, convergent, discriminant, and predictive validity of the YGTSS have been rigorously established in pediatric, adolescent, and adult cohorts across diverse clinical and cross-cultural settings.

Convergent Validity

Convergent validity has been repeatedly demonstrated through robust, statistically significant correlations between the YGTSS subscales and alternative clinician-rated or parent-rated tic instruments. In the initial validation study by Leckman et al. (1989), the Total Tic Score correlated strongly with the Tourette Syndrome Global Scale (TSGS; $r = .86, p < .001$) and the Shapiro Tourette-Syndrome Severity Scale (STSSS;$r = .84, p < .001$). Subsequent large-scale investigations (e.g., Storch et al., 2005) confirmed substantial associations between the YGTSS Total Tic Score and the Clinical Global Impression-Severity Scale (CGI-S;$r = .68$ to $.78$), demonstrating that the scale accurately captures global clinical impressions of tic disorder severity.

Discriminant Validity

A critical psychometric strength of the YGTSS is its ability to differentiate tic severity from common psychiatric comorbidities that frequently co-occur with Tourette Syndrome, such as Obsessive-Compulsive Disorder (OCD), Attention-Deficit/Hyperactivity Disorder (ADHD), generalized anxiety, and major depressive disorder. In a definitive study evaluating the psychometric properties of the YGTSS in an outpatient youth cohort, Storch et al. (2013) demonstrated that the Total Tic Score exhibited negligible to non-significant correlations with:

• OCD severity measured by the Children’s Yale-Brown Obsessive Compulsive Scale (CY-BOCS; $r = .01$ to $.15$);
• Parent-rated externalizing and internalizing problem behaviors on the Child Behavior Checklist (CBCL; $r = .07$ to $.20$);
• Child-rated depressive symptoms on the Children’s Depression Inventory (CDI; $r = .02$ to $.26$);
• Child-rated anxiety symptoms on the Multidimensional Anxiety Scale for Children (MASC; $r = .06$ to $.28$).

These findings confirm that the YGTSS Total Tic Score specifically indexes core tic pathology rather than non-specific internalizing distress, disruptive behaviors, or obsessive-compulsive phenomena.

Treatment Sensitivity and Predictive Validity

The YGTSS possesses verified sensitivity to therapeutic change across dozens of randomized controlled trials (RCTs). Clinical trials evaluating pharmaceutical agents (such as aripiprazole, risperidone, and clonidine) and behavioral therapies (CBIT) demonstrate that reductions in YGTSS Total Tic Scores reliably mirror objective decreases in tic frequency and parent-reported functional gains. Receiver operating characteristic (ROC) and signal detection analyses conducted by Storch et al. (2011) identified that a 25% decrease in the YGTSS Total Tic Score corresponds to an optimal balance of sensitivity (87%) and specificity (84%) for classifying clinical treatment responders.

Reliability

The reliability of the YGTSS has been extensively documented, demonstrating high internal consistency, inter-rater reliability, and stability over brief re-test intervals across both clinical and research applications.

Internal Consistency

Estimates of internal consistency via Cronbach’s alpha have demonstrated high item-total cohesion across independent developmental and international cohorts. Storch et al. (2005, 2013) reported excellent Cronbach’s alpha reliability coefficients across sequential administrations:

• Total Motor Tic Score: $\alpha = .92$ (Administration 1) and $\alpha = .92$ (Administration 2);
• Total Phonic Tic Score: $\alpha = .93$ (Administration 1) and $\alpha = .93$ (Administration 2);
• Total Tic Score (Composite): $\alpha = .93$ (Administration 1) and $\alpha = .94$ (Administration 2).

The individual item-to-total correlations within each domain consistently exceed .70, confirming that the five dimensions (Number, Frequency, Intensity, Complexity, Interference) contribute meaningfully to their respective subscales without excessive conceptual redundancy.

Inter-Rater Reliability

Because the YGTSS relies on clinical evaluation following a semi-structured interview, inter-rater agreement is paramount. In the foundational validation by Leckman et al. (1989), pairs of independent clinicians observing identical live and videotaped patient interviews achieved intraclass correlation coefficients (ICCs) of:

• Motor Tic Score: $\text{ICC} = .85$;
• Phonic Tic Score: $\text{ICC} = .91$;
• Total Tic Score: $\text{ICC} = .89$;
• Overall Impairment: $\text{ICC} = .77$;
• Global Severity Score: $\text{ICC} = .85$.

Subsequent multi-site clinical trials (e.g., Walkup et al., 2008; Scahill et al., 2013) reported even higher inter-rater reliability coefficients, consistently obtaining ICC values between .90 and .98 following standardized interviewer training and calibration workshops.

Test-Retest Reliability

Given the waxing and waning nature of tics, test-retest reliability must be measured over an interval short enough to avoid natural biological fluctuations yet long enough to prevent rote recall bias. Studies utilizing a 7- to 14-day re-test interval in clinically stable, non-medication-adjusted cohorts have documented test-retest intraclass correlations ranging from $r = .77$ to $.90$, confirming the temporal stability of the instrument when clinical state is steady.

Factor Analysis

The latent dimensionality of the YGTSS has been investigated using both Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) to evaluate whether the hypothesized two-domain architecture accurately represents clinical reality.

Exploratory Factor Structure

In a milestone structural investigation, Storch, Murphy, et al. (2007) conducted an EFA with oblique rotation on the 10 core severity items in a cohort of children and adolescents with TS. The analysis unambiguously yielded a robust two-factor solution explaining the majority of total variance:

• Factor 1: Motor Tic Severity — Comprising the five motor dimensions (Number, Frequency, Intensity, Complexity, Interference), with salient factor loadings ranging from .73 to .91, and negligible cross-loadings on the phonic factor (all $< .25$).
• Factor 2: Phonic Tic Severity — Comprising the five vocal/phonic dimensions (Number, Frequency, Intensity, Complexity, Interference), with salient factor loadings ranging from .78 to .94, and cross-loadings on the motor factor $< .20$.

Confirmatory Factor Analytic Fit

Subsequent CFA investigations (e.g., Kircanski et al., 2010; Storch et al., 2013) formally contrasted competing structural models: a unidimensional single-factor model versus a two-factor correlated model (Motor Tics and Phonic Tics). The two-factor model demonstrated superior fit to the empirical data across standard structural equation modeling indices:

• Comparative Fit Index (CFI): $.96$ to $.98$ (exceeding the standard $.95$ threshold for excellent model fit);
• Tucker-Lewis Index (TLI): $.95$ to $.97$;
• Root Mean Square Error of Approximation (RMSEA): $.045$ to $.062$ (with $90%$ confidence intervals firmly below the $.08$ cutoff);
• Standardized Root Mean Square Residual (SRMR): $.038$ to $.048$.

The correlation between the latent Motor and Phonic factors in these models was moderate ($r \approx .45$ to $.55$), supporting the clinical observation that while motor and phonic tics often co-occur within Tourette Syndrome, their severity trajectories can diverge significantly within individual patients over time.

Instrument / Measurement Tool

• Instrument Name: Yale Global Tic Severity Scale (YGTSS)
• Original Authors: James F. Leckman, Mark A. Riddle, Martha T. Hardin, Sharon I. Ort, Kathy L. Swartz, Jim Stevenson, and Donald J. Cohen (1989)
• Assessment Type: Clinician-rated, semi-structured clinical interview
• Target Population: Children, adolescents, and adults (ages 6 to 17 in standard pediatric norms; widely applied across the lifespan in contemporary clinical practice)
• Surveillance Window: The preceding week (past 7 to 10 days)
• Administration Time: Approximately 15 to 25 minutes (inclusive of symptom checklist and severity rating probes)
• Instrument Structure:
  • Phase 1: Tic Inventory Checklist: A comprehensive categorical review of motor and phonic tics (present vs. absent, past vs. current) to identify active symptoms over the past week.
  • Phase 2: Dimensional Severity Ratings: 10 items assessing the active tics across five dimensions for Motor (Items 1–5) and Phonic (Items 6–10) modalities.
  • Phase 3: Overall Impairment Rating: 1 global rating item (Item 11) evaluating functional disruption.
• Item Count: 11 scored clinical items (5 Motor items, 5 Phonic items, 1 Impairment item)
• Response Scales:
  • Severity Dimensions (Items 1–10): 0 to 5 ordinal rating scale for severity dimensions (0 = None, 1 = Minimal, 2 = Mild, 3 = Moderate, 4 = Marked, 5 = Severe).
  • Overall Impairment (Item 11): 0 to 50 ordinal rating scale for Overall Impairment (anchored in 10-point increments: 0 = None, 10 = Minimal, 20 = Mild, 30 = Moderate, 40 = Marked, 50 = Severe).
• Scoring and Computational Rules:
  • Total Motor Tic Score: Sum of Items 1 through 5 (Range: 0 to 25)
  • Total Phonic Tic Score: Sum of Items 6 through 10 (Range: 0 to 25)
  • Total Tic Score: Total Motor Tic Score + Total Phonic Tic Score (Range: 0 to 50)
  • Global Severity Score: Total Tic Score + Overall Impairment Score (Range: 0 to 100)
• Score Interpretation Benchmarks:
  • Total Tic Score (0–50): 0 = No active tics; 1–19 = Mild tic severity; 20–34 = Moderate tic severity; 35–50 = Severe to extreme tic severity.
  • Overall Impairment (0–50): 0 = None; 10 = Minimal; 20 = Mild; 30 = Moderate; 40 = Marked; 50 = Severe incapacitation.
  • Treatment Response Threshold: A reduction of ≥ 25% to 35% in Total Tic Score typically signifies a clinically meaningful therapeutic response.

Permissions & Fee and Test Year

The Yale Global Tic Severity Scale was initially published in 1989 by the Yale Child Study Center research team in the Journal of the American Academy of Child and Adolescent Psychiatry. In the tradition of public academic clinical psychiatry, the original English instrument was placed in the public domain for clinical practice and non-commercial academic research. Clinicians and independent investigators may utilize and administer the YGTSS without paying per-administration royalty fees or obtaining commercial test publisher licensing, provided appropriate bibliographic attribution is given to the original authors and the Yale Child Study Center.

For commercial use, including large-scale industry-sponsored pharmaceutical clinical trials, electronic electronic clinical outcome assessment (eCOA) digitization, or formal software integration, entities typically contact the Yale Child Study Center or Yale University Office of Cooperative Research to secure authorized master copies and confirm adherence to standardized administration protocols.

References

• Kircanski, K., Woods, D. W., Chang, S. W., Ricketts, E. J., & Piacentini, J. (2010). Cluster analysis of the Yale Global Tic Severity Scale (YGTSS): Symptom dimensions and clinical correlates in an outpatient youth sample. Journal of Abnormal Child Psychology, 38(6), 777–788. https://doi.org/10.1007/s10802-010-9410-0
• Leckman, J. F., Riddle, M. A., Hardin, M. T., Ort, S. I., Swartz, K. L., Stevenson, J., & Cohen, D. J. (1989). The Yale Global Tic Severity Scale: Initial testing of a clinician-rated scale of tic severity. Journal of the American Academy of Child and Adolescent Psychiatry, 28(4), 566–573. https://doi.org/10.1097/00004583-198907000-00015
• Scahill, L. (2013). Yale Global Tic Severity Scale. In F. R. Volkmar (Ed.), Encyclopedia of Autism Spectrum Disorders (p. 3415). Springer New York. https://doi.org/10.1007/978-1-4419-1698-3_301
• Selles, R. R., Murphy, T. K., Obregon, D., Storch, E. A., & Lewin, A. B. (2013). Treatment decisions for chronic tic disorders. Clinical Practice, 10(6), 765–780. https://doi.org/10.2217/cpr.13.58
• Storch, E. A., De Nadai, A. S., Lewin, A. B., McGuire, J. F., Jones, A. M., Mutch, P. J., & Murphy, T. K. (2011). Defining treatment response in pediatric tic disorders: A signal detection analysis of the Yale Global Tic Severity Scale. Journal of Child and Adolescent Psychopharmacology, 21(6), 621–627. https://doi.org/10.1089/cap.2011.0039
• Storch, E. A., Murphy, T. K., Fernandez, M., Krishnan, M., Geffken, G. R., Kellgren, A. R., & Goodman, W. K. (2007). Factor-analytic study of the Yale Global Tic Severity Scale. Psychiatry Research, 149(1–3), 231–237. https://doi.org/10.1016/j.psychres.2006.03.013
• Storch, E. A., Murphy, T. K., Geffken, G. R., Sajid, M., Allen, P., Roberti, J. W., & Goodman, W. K. (2005). Reliability and validity of the Yale Global Tic Severity Scale. Psychological Assessment, 17(4), 486–491. https://doi.org/10.1037/1040-3590.17.4.486
• Walkup, J. T., Ferrão, Y., Leckman, J. F., Stein, D. J., & Singer, H. (2008). Tic disorders and Tourette syndrome. In M. Rutter, D. Bishop, D. Pine, S. Scott, J. Stevenson, E. Taylor, & A. Thapar (Eds.), Rutter’s Child and Adolescent Psychiatry (5th ed., pp. 696–711). Blackwell Publishing.

Items of the Scale